CCL4 News and Research

RSS
What genes affect the COVID-19 gender imbalance?

What genes affect the COVID-19 gender imbalance?

Investigation of Budesonide's mechanism of action against SARS-CoV-2

Investigation of Budesonide's mechanism of action against SARS-CoV-2

The role of natural killer cells in fight against viral infections including SARS-CoV-2

The role of natural killer cells in fight against viral infections including SARS-CoV-2

Research looks at inflammatory nature of lipid nanoparticle component in mRNA vaccines

Research looks at inflammatory nature of lipid nanoparticle component in mRNA vaccines

Immunologic modeling of COVID-19 severity and chronicity

Immunologic modeling of COVID-19 severity and chronicity

Researchers generate a transcriptomic map of the COVID brain

Researchers generate a transcriptomic map of the COVID brain

Anti-CD73 molecule CPI-006 activates B cell responses to SARS-CoV-2

Anti-CD73 molecule CPI-006 activates B cell responses to SARS-CoV-2

High-level quantum chemical computations help unravel underlying mechanism of hepatocellular toxicity

High-level quantum chemical computations help unravel underlying mechanism of hepatocellular toxicity

Study: Disrupting cancer pathway could extend benefits of new immunity-boosting drugs

Study: Disrupting cancer pathway could extend benefits of new immunity-boosting drugs

Capsaicin has beneficial effects on liver damage, study reveals

Capsaicin has beneficial effects on liver damage, study reveals

Scientists potentially discover new therapeutic targets to halt progression of tumor cells

Scientists potentially discover new therapeutic targets to halt progression of tumor cells

IMBRUVICA-rituximab combination well tolerated in patients with relapsed or refractory MCL

IMBRUVICA-rituximab combination well tolerated in patients with relapsed or refractory MCL

Exposure to TCE, PERC and CCI4 may increase risk of Parkinson's

Exposure to TCE, PERC and CCI4 may increase risk of Parkinson's

Calistoga Pharmaceuticals presents CAL-101 PI3K inhibitor data at European Hematology Association Congress

Calistoga Pharmaceuticals presents CAL-101 PI3K inhibitor data at European Hematology Association Congress

Short-term dose of losartan-M6PHSA reduces liver inflammation and fibrosis: Study

Short-term dose of losartan-M6PHSA reduces liver inflammation and fibrosis: Study

Study shows ghrelin prevents acute liver damage, reduces oxidative stress and inflammation

Study shows ghrelin prevents acute liver damage, reduces oxidative stress and inflammation

Emodin raises hope for treatment of fibrotic liver diseases

Emodin raises hope for treatment of fibrotic liver diseases

Melatonin may be served as a potential anti-fibrotic drug

Melatonin may be served as a potential anti-fibrotic drug